via National Human Genome Research Institute
Researchers from the University of Sheffield have discovered a new gene therapy pathway that has the potential to protect us against serious life-limiting diseases such as cancer and dementia
Researchers from the University of Sheffield have discovered a new gene therapy pathway that has uncovered an important regulatory mechanism to keep our genome healthy. This pathway has the potential to protect us against serious life-limiting diseases such as cancer and dementia.
Cancer and neurodegeneration are two major health challenges currently affecting the population, and they constitute two sides of the same coin – one is caused by uncontrolled cell proliferation due to genome damage, and the other is caused by excessive genome damage that causes cell death. This new pathway impacts both and offers new therapeutic opportunities to help the fight against disease.
Published in Nature Communications, the research found that when cells in our body read DNA to build proteins, they often make mistakes that can damage our genome, causing disease such as cancer and dementia. However, by investigating how cells fix damage in the DNA to keep us healthy, scientists have discovered the benefits of three proteins working together as a team. The three proteins, called USP11, KEAP1 and SETX, receive instructions from their coach to direct their function in space and time with remarkable harmony, to keep our DNA healthy.
By understanding how cells protect themselves from these mistakes and thus preventing diseases, scientists are able to modify the behaviour of these proteins to promote the health and wellbeing of people.
Findings from this study will enable scientists to develop diagnostic tests and drugs to target one or more of the proteins in the pathway for the early detection and treatment of certain types of cancer and neurological disease. Developing new drugs to regulate the level of one or more of these proteins is expected to offer new treatments for cancer and dementia.
The findings are important and significant, this is because we are now at the stage where we could make drugs to control this modification. This would be useful in killing cells, which is what we do when we treat elderly people for cancer. The other application would be to reduce the level of genome damage, which could be beneficial for other ageing associated disorders like dementia.
Original Article: New gene therapy pathway could protect us from cancer and dementia
More from: University of Sheffield
The Latest on: Gene therapy pathway
- Thought Leaders on Gene Editing, Cancer Immunotherapy and Vaccines Convene at Drexel’s National Symposium for Immune Modulation and Engineeringon December 6, 2022 at 1:40 pm
How can scientists develop new ways to change our immune systems to treat disease and help the body heal from injury? National leaders in the rapidly growing field of immune engineering pursuing these ...
- Vertex-partnered gene therapy biotech Affinia scraps IPO planson December 6, 2022 at 4:07 am
Affinia Therapeutics has ditched its plans to go public in a relatively closed-door market that has not favored Nasdaq debuts for the drug development industry most of this year. A pandemic surge in ...
- Data backs gene therapy delivery system for treating type 2 diabetes from Fractyl Healthon December 5, 2022 at 8:32 am
Fractyl Health announced positive preclinical proof-of-concept data in an animal model for its gene therapy for treating type 2 diabetes.
- To trigger Crohn's disease, pathogenic bacteria co-opt a genetic susceptibilityon December 3, 2022 at 5:02 pm
Changes in a single gene open the door for harmful gut bacteria to set off the inflammation that drives Crohn's disease, according to a new study. These findings could one day help doctors better ...
- FDA Giving SRP-9001, DMD Gene Therapy, Priority Reviewon November 29, 2022 at 9:40 am
An approval request for SRP-9001, gene therapy for ambulatory Duchenne MD patients, is under priority review in US; decision likely in May.
- Mission Bio's single-cell transduction assay adopted for AVROBIO's gene therapy pipelineon November 29, 2022 at 7:29 am
Transduction percentage is a critical quality attribute for cell and gene therapy manufacturing ... cell and gene therapies that provide new pathways to health. Founded in 2014, Mission Bio ...
- Fourth accelerated approval in Duchenne? Sarepta gets priority review for gene therapy amid FDA scrutinyon November 28, 2022 at 8:26 am
Sarepta is once again on the accelerated approval path for a Duchenne drug, picking up a priority review Monday morning. The FDA granted the accelerated review to SRP-9001, Sarepta announced Monday, ...
- Lab discovers new pathway for antimicrobial peptideson November 14, 2022 at 8:23 am
"The way this pathway works is that the ribosome makes a precursor peptide, which is then acted on by metalloenzymes encoded in the same gene cluster," said Clark. "The series of metalloenzymes ...
- New pathway for antimicrobial peptideson November 13, 2022 at 4:01 pm
Researchers have discovered a new multi-step pathway through which bacteria found in the mammalian gut produce antimicrobial peptides. Researchers in the Princeton University Department of ...
- Gene Therapyon December 12, 2021 at 6:50 pm
both of which were abnormal before gene therapy. These findings were important, because they indicated that the visual pathway indeed retains the ability to respond to light and that the visual ...
via Bing News
The Latest on: Gene therapy pathway
[google_news title=”” keyword=”gene therapy pathway” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
Add Comment